In summary, we have shown for the first time that DRAK2 expression is linked to Overall Survival (OS) in CLL patients, potentially through regulation of cell survival and proliferation critical for leukemic cell fate. This evidence concerns the gene STK17B and B-cell chronic lymphocytic leukemia.